+27 (0)83 440 0793 mark.fyvie@vxpharma.com
Select Page

VX IN THE NEWS

Read all about it and stay up to date with the latest developments in medical research and breakthrough science & technology

PRESS RELEASES

FLAIR PRESS RELEASE – ViiV Healthcare reports positive 48-week results

   

FDA APPROVAL OF ASTHMA INDICATION FOR DUPIXENT® (DUPILUMAB)

AFFILIATES & ALLIANCES